Sucunamostat

N/A

Report date: 2024/03/04 10:41:06
NME

Base Information

Drug NameSucunamostat
Drug Alias NameSCO-792TAK-792
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnteropeptidase inhibitors
TargetsEnteropeptidase
Therapy Area/IndicationsObesityNephrotic SyndromeDiabetic Nephropathies +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesScohia Pharma Inc
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsObesityNephrotic SyndromeDiabetic Nephropathies +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A